Suppr超能文献

12 个月以下因细支气管炎住院的儿童与健康儿童的肠道和呼吸道微生物群比较:我们能否预测严重程度和中期呼吸结局?

Gut and respiratory tract microbiota in children younger than 12 months hospitalized for bronchiolitis compared with healthy children: can we predict the severity and medium-term respiratory outcome?

机构信息

Department of Biotechnology, Institute of Agrochemistry and Food Technology-National Research Council (IATA-CSIC), Paterna, Valencia, Spain.

Paediatric Infectious Diseases Department, La Paz University Hospital, Madrid, Spain.

出版信息

Microbiol Spectr. 2024 Jul 2;12(7):e0255623. doi: 10.1128/spectrum.02556-23. Epub 2024 May 24.

Abstract

UNLABELLED

Growing evidence indicates that gut and respiratory microbiota have a potential key effect on bronchiolitis, mainly caused by respiratory syncytial virus (RSV). This was a prospective study of 96 infants comparing infants with bronchiolitis ( = 57, both RSV and non-RSV associated) to a control group ( = 39). Gut (feces) and respiratory [nasopharyngeal aspirate (NPA)] microbial profiles were analyzed by 16S rRNA amplicon sequencing, and respiratory viruses were identified by PCR. Clinical data of the acute episode and follow-up during the first year after infection were recorded. Pairwise comparisons showed significant differences in the gut ( = 0.0639, = 0.006) and NPA ( = 0.0803, = 0.006) microbiota between cases and controls. A significantly lower gut microbial richness and an increase in the NPA microbial diversity (mainly due to an increase in , and ) were observed in the infants with bronchiolitis, in those with the most severe symptoms, and in those who subsequently developed recurrent wheezing episodes after discharge. In NPA, the higher microbial richness differed significantly between the control group and the non-RSV bronchiolitis group ( = 0.01) and between the control group and the RSV bronchiolitis group ( = 0.001). In the gut, the richness differed significantly between the control group and the non-RSV group ( = 0.01) and between the control group and the RSV bronchiolitis group ( = 0.001), with higher diversity in the RSV group. A distinct respiratory and intestinal microbial pattern was observed in infants with bronchiolitis compared with controls. The presence of RSV was a main factor for dysbiosis. Lower gut microbial richness and increased respiratory microbial diversity were associated with respiratory morbidity during follow-up.

IMPORTANCE

Both the intestinal and respiratory microbiota of children with bronchiolitis, especially those with respiratory syncytial virus infection, are altered and differ from that of healthy children. The microbiota pattern in the acute episode could identify those children who will later have other respiratory episodes in the first year of life. Preventive measures could be adopted for this group of infants.

摘要

未加标签

越来越多的证据表明,肠道和呼吸道微生物群对细支气管炎具有潜在的关键影响,主要由呼吸道合胞病毒(RSV)引起。这是一项对 96 名婴儿的前瞻性研究,将细支气管炎婴儿(=57 名,包括 RSV 和非 RSV 相关)与对照组(=39 名)进行比较。通过 16S rRNA 扩增子测序分析肠道(粪便)和呼吸道[鼻咽抽吸物(NPA)]微生物谱,并通过 PCR 鉴定呼吸道病毒。记录急性发作期间和感染后第一年的临床数据。成对比较显示病例组和对照组之间的肠道(=0.0639,=0.006)和 NPA(=0.0803,=0.006)微生物群存在显著差异。在细支气管炎婴儿中观察到肠道微生物丰富度显著降低,NPA 微生物多样性增加(主要是由于 、 和 的增加),在症状最严重的婴儿中,以及在出院后随后出现反复喘息发作的婴儿中。在 NPA 中,对照组和非 RSV 细支气管炎组之间(=0.01)和对照组和 RSV 细支气管炎组之间(=0.001)的微生物丰富度差异显著。在肠道中,对照组和非 RSV 组之间(=0.01)和对照组和 RSV 细支气管炎组之间(=0.001)的丰富度差异显著,RSV 组的多样性更高。与对照组相比,细支气管炎婴儿的呼吸道和肠道微生物模式明显不同。RSV 的存在是菌群失调的主要因素。随访期间,肠道微生物丰富度降低和呼吸道微生物多样性增加与呼吸道发病率有关。

重要性

细支气管炎患儿的肠道和呼吸道微生物群,特别是呼吸道合胞病毒感染患儿的肠道和呼吸道微生物群发生改变,与健康儿童不同。急性发作期间的微生物群模式可以识别出那些在生命的第一年以后会有其他呼吸道发作的儿童。可以为这组婴儿采取预防措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6089/11218511/e874a6ce0014/spectrum.02556-23.f001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验